← Back to Search

Transcutaneous CO2 monitoring for Neuromuscular Disease

N/A
Waitlist Available
Led By Reshma Amin, MD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights

Study Summary

This trial is testing whether an at-home carbon dioxide monitor can help diagnose nocturnal hypoventilation in children with neuromuscular disorders.

Eligible Conditions
  • Neuromuscular Disease
  • Central Sleep Apnea
  • Obstructive Sleep Apnea
  • Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sensitivity and specificity of ambulatory, at home, transcutaneous CO2 (tcCO2) monitoring to diagnose nocturnal hypoventilation as compared to the gold standard, end tidal CO2 conducted during polysomnogram (PSG).
Secondary outcome measures
a) Agreement of tcCO2 monitoring when worn in the ambulatory, at home, setting compared to tcCO2 recorded during a PSG in a hospital based sleep laboratory for diagnosis of nocturnal hypoventilation.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transcutaneous CO2 monitoringExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
686 Previous Clinical Trials
6,944,754 Total Patients Enrolled
Reshma Amin, MDPrincipal InvestigatorStaff Physician
2 Previous Clinical Trials
43 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Transcutaneous CO2 Monitoring at Home for Children With Neuromuscular Disease
Reshma Amin 2018. "Transcutaneous CO2 Monitoring at Home for Children With Neuromuscular Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03478566.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top